The ACR is aware of an impending shortage of quinacrine in the U.S. We have alerted the FDA, and the ACR and partnering organizations are working with the FDA Center for Drug Evaluation and Research, Shortage Division, to address this issue. If you are experiencing a lapse in availability of quinacrine or have questions, contact ACR staff at advocacy@rheumatology.org.
Quinacrine Shortage & What the ACR Is Doing about It
• By From the College
- Tweet